Accelerating Diagnostic Adoption:
Gaining

Prescription

    • Visual Identity
    • Design Systems
    • Creative Campaigns & Production
    • Sales Enablement & Product Marketing
    • Digital
    • Animation & Video
    • SEO/AEO/GEO
    • Event Planning
    • Booth/Exhibit Creation

Premise

Oncology is super complex, to say the least. HCPs couldn’t always determine whether a patient had residual disease after treatment until cancer became detectable through conventional imaging or clinical symptoms. With an ultrasensitive liquid biopsy platform for detecting minimal residual disease (MRD), treatment effectiveness, recurrence and monitoring could be improved if awareness could be increased and oncologist adoption was more widespread.

Precedent

An integrated approach including brand evolution, animation, product packaging, new reporting, social media and live events translated a highly technical scientific breakthrough into a compelling clinical and commercial value proposition. The “Seeing Care Forward” campaign communicated the value of detecting cancer earlier and more precisely, as well as how MRD data could enable life-changing decision-making.

Case Study 05 brand idea: Seeing Care Forward, set in a pink to teal gradient beside a wireframe helix
Case Study 05 digital work: press release post, conference post, the Walk with Case Study 05 team, keynote template and webinar template
Case Study 05 brand system: Seeing Care Forward in Proxima Nova, the reversed lockup and clear space, Case Study 05 Clarity, colour, datalines and dot field, the Walk with Case Study 05 T-shirts, labels and calls to action
Case Study 05 CLARITY packaging: the Blood and Tissue Collection Kit boxes, beside the publication summary on PhasED-Seq MRD detection in B-cell lymphoma and the CLARITY Dx MRD result report
The Case Study 05 Clarity conference booth, Seeing Care Forward on the back wall, attendees walking past

More work.